Acsys Biometrics Chooses Wizzard Software to Add Voice to Facial Recognition Products

PITTSBURGH--(BUSINESS WIRE)--Jan. 19, 2005--Wizzard Software (OTCBB:WIZD) announced today that the Ontario-based Acsys Biometrics has licensed AT&T's Natural Voices speech engine for use in their facial recognition products. Acsys Biometrics is a leading provider of neural technology, which consists of technology that emulates the analytical processes of the human mind. Ideal for industries that require high level security systems, their Face Recognition System (FRS) is capable of fulfilling all biometric security needs relating to identity authentication, controlled access and surveillance. Acsys Biometrics' customer base includes the U.S. government and the Department of Veterans' Affairs.

"We performed a quality test among several vendors and found that AT&T's product provided the most natural sounding voice and most accurate pronunciation," said John Sutherland of Acsys Biometrics. Sutherland believes adding speech technology to their products "provides a higher dimension of user interactivity and realizes a new level of office automation and alarm features."

“We performed a quality test among several vendors and found that AT&T's product provided the most natural sounding voice and most accurate pronunciation”

Biometrics is the science of using biological properties to identify individuals, such as finger prints or a retina scan. Acsys Biometrics' advanced technology recognizes facial features at different angles, and will learn that and compare it to other people's features to verify an individual's identity. AT&T's Natural Voices is used in their voice synthesis product to provide voice feedback during facial enrollment, and to verify and classify operations. For example, random customized greetings can be added when an individual enters the camera's field of few, such as "Hello John, did you register with the receptionist" or "Sally, you have e-mail."

"The addition of AT&T Natural Voices to add voice personality to Acsys Biometrics' facial recognition technology is brilliant," said Bruce Phifer, Wizzard General Manager of Market/Business Development. "We are pleased that Acsys Biometrics chose Wizzard and AT&T Natural Voices to provide their voice component and are very excited about this combination of technologies, which clearly exemplifies the value of using human interface technology to connect an emerging high tech product directly with its users."

About Acsys Biometrics:

Acsys Biometrics is a joint venture between NEXUS Group International Inc. and AND Corporation, the owner and developer of the patented, proprietary Holographic/Quantum Neural Technology (HNeT). Acsys is the leading-edge provider of facial recognition through its exclusive worldwide license for face and speech recognition based on the core software -- HNeT - with applications for the financial, manufacturing, security and medical sectors. NEXUS is a Burlington, Ontario-based, organization focused on leading-edge technologies with a primary focus on the security market. Its goal is to position itself as the leader in biometric technology and other advanced fields. NEXUS trades on the Toronto Stock Exchange as NXS. For more information, visit www.acsysbiometrics.com.

About Wizzard Software:

Founded in 1996, Wizzard Software has become a leader in the speech technology application development market. Wizzard architects solutions to business problems using its expertise in consulting, speech development tools and building speech based applications for the Desktop and Internet. Wizzard has achieved global recognition because of its expertise with voice communication whether it is via PC or telephone. Wizzard's successes have lead to expanding opportunities in both the government and commercial sectors. In April of 2004, Wizzard acquired MedivoxRx Technologies. Founded in 2000, MedivoxRx is the originator of "Rex", the talking prescription pill bottle, which "talks" to the patient allowing them to distinguish what type of medication is in the bottle and hear critical information on dosage amounts and refill parameters. Additional information on MedivoxRx can be found at www.rxtalks.com. More information on Wizzard Software can be found on the Investor's Page at www.wizzardsoftware.com.

Legal Notice Regarding Forward-Looking Statements:

"Forward-looking Statements" as defined in the Private Securities litigation Reform Act of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, changes in our business strategies and acts of terror against the United States.